Open Access

REVIEW

Mohammad Reza Haghshenas¹, Mina Roshan Zamir¹, Mahboubeh Sadeghi¹, Mohammad Javad Fattahi¹, Kimia Mirshekari¹, Abbas Ghaderi^1,2,*
European Cytokine Network, Vol.33, No.3, pp. 54-69, 2022, DOI:10.1684/ecn.2022.0480
Abstract Interleukin-38 (IL-38) is the most recent member of the IL-1 family that acts as a natural inflammatory inhibitor by binding to cognate receptors, particularly the IL-36 receptor. In vitro, animal and human studies on autoimmune, metabolic, cardiovascular and allergic diseases, as well sepsis and respiratory viral infections, have shown that IL-38 exerts an anti-inflammatory activity by modulating the generation and function of inflammatory cytokines (e.g. IL-6, IL-8, IL-17 and IL-36) and regulating dendritic cells, M2 macrophages and regulatory T cells (Tregs). Accordingly, IL-38 may possess therapeutic potential for these types of diseases. IL-38 down-regulates CCR3+… More >

View

23

Download

27

Open Access

ARTICLE

Fatemeh Bayati^1,*, Maryam Valadi^1,*, Armin Ahmadi^1,2, Farangis Najaf¹, Bita Ansaripour¹, Ehsan Sharif-Paghaleh^1,3
European Cytokine Network, Vol.33, No.3, pp. 70-78, 2022, DOI:10.1684/ecn.2022.0482
Abstract Although mesenchymal stem cells (MSCs) have exhibited promising immunomodulatory potential in preclinical studies, clinical studies have revealed variable results. These results often depend on environmental cues. Pre-conditioning MSCs with cytokines is one of the methods used to enhance their immunomodulatory effects. In this study, we harvested adipose-derived MSCs from mice and cultured them with different doses of the cytokine, IFN-γ, and the corticosteroid drug, dexamethasone, in order to investigate their effects on MSC immunosuppressive function. We found the co-culture or supernatant of MSCs, pre-conditioned with IFN-γ, together with spleen mononuclear cells resulted in a significant More >

View

22

Download

21